Pulling SEC filings + quote and writing the call…
TRVI
Trevi Therapeutics, Inc.
Next earnings Aug 5, 2026 · consensus $-0.11 EPS
Last earnings +1.9% on 2026-05-05
$17.71
▲ +2.91%$17.71▲ +179.56%
over 1Y
L $5.47EODHDH $17.71
Earnings Dividend Split Congress buy Congress sellFilings colored by tone · hover for detail
Today+2.9%
1W+20.8%
1M+23.2%
3M+64.6%
YTD+48.9%
1Y+179.6%
Hold
Conviction
Horizon
Medium (3–12mo)
Street · 17 analysts
Buy
Conservative balance sheet (liabilities/equity 0.06x).
Trevi Therapeutics, Inc. shows limited reported revenue, and -23.3% ROE.
Sources: SEC EDGAR (CIK 0001563880, latest 10-Q filed 2026-05-05) · EODHD · as of 6/22/2026, 10:26:21 PM.
Research and education only — not financial advice. Calls are generated from SEC filings and a delayed/third-party price feed, may be wrong or out of date, and are not a recommendation to buy or sell any security. Do your own research.